← Leaderboards
Miguel Otero
Universidad Central Del Caribe
$963,196
Attributed
$963,196
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $180.8K · FY2010–19$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$963,196 · 5
By mechanism
SC3$450,000 · 1
G12$410,588 · 3
P20$102,608 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingVaccinationVaccinesCellsAntigensImmune ResponseEnzyme Linked Immunospot AssayImmunomodulatorsClinicViremiaInterferon Type IiBaseImmunizationSerumProtocols DocumentationGenesResourcesRouteDna VaccinesMemoryPlasmid DnaEnzyme-Linked Immunosorbent AssayInfluenzaAdjuvant
Grant awards (9)
Vaccine Development against Infectious Diseases$112,500
SC3 · FY2019 · GM · contact PI
Vaccine Development against Infectious Diseases$112,500
SC3 · FY2018 · GM · contact PI
Vaccine Development against Infectious Diseases$112,500
SC3 · FY2017 · GM · contact PI
Vaccine Development against Infectious Diseases$112,500
SC3 · FY2016 · GM · contact PI
IMMUNOMODULATOR-MEDIATED ENHANCEMENT OF ANTI-HIV-SPECIFIC IMMUNE RESPONSE$122,406
G12 · FY2013 · MD · contact PI
IMMUNOMODULATOR-MEDIATED ENHANCEMENT OF ANTI-HIV-SPECIFIC IMMUNE RESPONSE$130,916
G12 · FY2012 · MD · contact PI
DEVELOPMENT OF A VIRUS-FREE DNA VACCINE AGAINST SMALLPOX$102,608
P20 · FY2011 · RR · contact PI
IMMUNOMODULATOR-MEDIATED ENHANCEMENT OF ANTI-HIV-SPECIFIC IMMUNE RESPONSE$78,217
G12 · FY2011 · RR · contact PI
IMMUNOMODULATOR-MEDIATED ENHANCEMENT OF ANTI-HIV-SPECIFIC IMMUNE RESPONSE$79,049
G12 · FY2010 · RR · contact PI